Back to Search
Start Over
Vemurafenib-resistant BRAF selects alternative branch points different from its wild-type BRAF in intron 8 for RNA splicing.
- Source :
-
Cell & bioscience [Cell Biosci] 2015 Dec 21; Vol. 5, pp. 70. Date of Electronic Publication: 2015 Dec 21 (Print Publication: 2015). - Publication Year :
- 2015
-
Abstract
- One mechanism of resistance of the melanoma-associated BRAF kinase to its small molecule inhibitor vemurafenib is by point mutations in its intron 8 resulting in exons 4-8 skipping. In this report, we carried out in vitro BRAF RNA splicing assays and lariat RT-PCR to map the intron 8 branch points in wild-type and BRAF mutants. We identify multiple branch points (BP) in intron 8 of both wild-type (wt) and vemurafenib-resistant BRAF RNA. In wt BRAF, BPs are located at -29A, -28A and -26A, whereas in a vemurafenib-resistant BRAF splicing mutant, BPs map to -22A, -18A and -15A, proximal to the intron 8 3' splice site. This finding of a distal-to-proximal shift of the branch point sequence in BRAF splicing in response to point-mutations in intron 8 provides insight into the regulation of BRAF alternative splicing upon vemurafenib resistance.
Details
- Language :
- English
- ISSN :
- 2045-3701
- Volume :
- 5
- Database :
- MEDLINE
- Journal :
- Cell & bioscience
- Publication Type :
- Academic Journal
- Accession number :
- 26697165
- Full Text :
- https://doi.org/10.1186/s13578-015-0061-7